Protective effect and mechanism of stronger neo-minophagen C against fulminant hepatic failure

Table 1 Levels of NO, TNF-α, ET-1, IL-6, ALT, ALB, and TBIL in control, model and treatment groups(mean±SD)

Groups	Mice (n)	NO (μmol/L)	TNF-α (ng/mL)	ET-1 (pg/mL)	IL-6 (pg/mL)	ALT (u/L)	ALB (g/L)	TBIL (u/L)
Control group	6	45.1 ± 14.01	0.77 ± 0.08	50.8 ± 7.58	57.07 ± 12.67	67.17 ± 12.62	32.18 ± 4.16	9.2 ± 8.75
Model group	6	725.94 ± 156.94	3.75 ± 0.50	309.41 ± 38.45	413.56 ± 69.02	1406.33 ± 47.42	21.13 ± 3.66	70.03 ± 17.22
Treatment group	6	199.42 ± 85.98	1.34 ± 0.31	129.11 ± 17.97	155.22 ± 59.37	799.33 ± 171.19	20.03 ± 3.01	8.87 ± 0.85
140 mL group	6	215.01 ± 28.72	1.35 ± 0.17	183.07 ± 75.93	149.81 ± 44.69	25.96 ± 6.35	26.10 ± 1.97	59 ± 29.31
200 mL group	6	87.88 ± 12.46	1.34 ± 0.31	157.41 ± 35.64	133.89 ± 30.48	1169 ± 149.92	20.9 ± 1.28	27.33 ± 2.94
280 mL group	6	184.54 ± 19.84	1.27 ± 0.27	216.15 ± 24.47	179.97 ± 65.09	24.33 ± 8.02	21.37 ± 5.44	51.5 ± 14.94

F_(4,29) = 2.70.